MMP9 and Cognitive impairment: In parallel, independently of the presence of vascular risk factors, elevated serum MMP-9 levels are associated with mild (25.6% of patients) and severe (27.4%) cognitive impairment 3 months following stroke according to the Mini-Mental State Examination and Montreal Cognitive Assessment (Zhong et al., 2018).